HomeOGN • NYSE
add
Organon & Co
Previous close
$10.66
Day range
$10.50 - $10.72
Year range
$8.01 - $21.06
Market cap
2.77B USD
Avg Volume
4.43M
P/E ratio
3.96
Dividend yield
0.75%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.59B | -0.81% |
Operating expense | 548.00M | -0.90% |
Net income | 145.00M | -25.64% |
Net profit margin | 9.10 | -24.98% |
Earnings per share | 1.00 | -10.71% |
EBITDA | 425.00M | -5.97% |
Effective tax rate | 36.68% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 599.00M | -14.91% |
Total assets | 13.50B | 11.07% |
Total liabilities | 12.77B | 6.30% |
Total equity | 733.00M | — |
Shares outstanding | 259.97M | — |
Price to book | 3.78 | — |
Return on assets | 6.30% | — |
Return on capital | 8.78% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 145.00M | -25.64% |
Cash from operations | 220.00M | -33.73% |
Cash from investing | -38.00M | 17.39% |
Cash from financing | -223.00M | -66.42% |
Net change in cash | 52.00M | -59.69% |
Free cash flow | 91.12M | -60.79% |
About
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Founded
1923
Headquarters
Website
Employees
10,000
